Pages that link to "Q24317631"
Jump to navigation
Jump to search
The following pages link to Adult neurogenesis and neurite outgrowth are impaired in LRRK2 G2019S mice (Q24317631):
Displaying 50 items.
- Leucine rich repeat kinase 2 (Q409961) (← links)
- Progressive degeneration of human neural stem cells caused by pathogenic LRRK2 (Q24301070) (← links)
- Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease (Q24336432) (← links)
- Mouse Genetic Models of Human Brain Disorders (Q26752246) (← links)
- The associations between Parkinson's disease and cancer: the plot thickens (Q26778641) (← links)
- Current understanding of LRRK2 in Parkinson's disease: biochemical and structural features and inhibitor design (Q26827527) (← links)
- The complex relationships between microglia, alpha-synuclein, and LRRK2 in Parkinson's disease (Q26853537) (← links)
- Adult hippocampal neurogenesis in Parkinson's disease: impact on neuronal survival and plasticity (Q26862840) (← links)
- Is inhibition of kinase activity the only therapeutic strategy for LRRK2-associated Parkinson's disease? (Q27026262) (← links)
- High LRRK2 levels fail to induce or exacerbate neuronal alpha-synucleinopathy in mouse brain (Q27303568) (← links)
- No dopamine cell loss or changes in cytoskeleton function in transgenic mice expressing physiological levels of wild type or G2019S mutant LRRK2 and in human fibroblasts (Q27312569) (← links)
- Parkinson's disease and immune system: is the culprit LRRKing in the periphery? (Q27687171) (← links)
- Dysregulation of autophagy and mitochondrial function in Parkinson's disease (Q28071890) (← links)
- LRRK2 inhibitors and their potential in the treatment of Parkinson's disease: current perspectives (Q28078899) (← links)
- Parkinson's disease: animal models and dopaminergic cell vulnerability (Q28080503) (← links)
- Leucine-rich repeat kinase 2 interacts with p21-activated kinase 6 to control neurite complexity in mammalian brain (Q28267434) (← links)
- FoxO3a negatively regulates nerve growth factor-induced neuronal differentiation through inhibiting the expression of neurochondrin in PC12 cells (Q28574521) (← links)
- Identification of Allele-Specific RNAi Effectors Targeting Genetic Forms of Parkinson's Disease (Q28743569) (← links)
- LRRK2 knockout mice have an intact dopaminergic system but display alterations in exploratory and motor co-ordination behaviors (Q30524899) (← links)
- Differential LRRK2 expression in the cortex, striatum, and substantia nigra in transgenic and nontransgenic rodents (Q33825413) (← links)
- Role of LRRK2 kinase dysfunction in Parkinson disease (Q34192817) (← links)
- Role of LRRK2 kinase activity in the pathogenesis of Parkinson's disease (Q34300430) (← links)
- Higher vulnerability and stress sensitivity of neuronal precursor cells carrying an alpha-synuclein gene triplication (Q34497765) (← links)
- Short- and long-term effects of LRRK2 on axon and dendrite growth (Q34706691) (← links)
- Bcl-xL is necessary for neurite outgrowth in hippocampal neurons (Q34802591) (← links)
- Models for LRRK2-Linked Parkinsonism (Q34986076) (← links)
- Temporal expression of mutant LRRK2 in adult rats impairs dopamine reuptake (Q35059247) (← links)
- Genetic LRRK2 models of Parkinson's disease: Dissecting the pathogenic pathway and exploring clinical applications (Q35148581) (← links)
- Leucine-rich repeat kinase 2 modulates neuroinflammation and neurotoxicity in models of human immunodeficiency virus 1-associated neurocognitive disorders (Q35236882) (← links)
- The Parkinson's Disease-Associated Protein Kinase LRRK2 Modulates Notch Signaling through the Endosomal Pathway. (Q35768943) (← links)
- The Parkinson's Disease-Associated Mutation LRRK2-G2019S Impairs Synaptic Plasticity in Mouse Hippocampus (Q35941370) (← links)
- Lovastatin protects neurite degeneration in LRRK2-G2019S parkinsonism through activating the Akt/Nrf pathway and inhibiting GSK3β activity (Q35941717) (← links)
- Small molecule kinase inhibitors for LRRK2 and their application to Parkinson's disease models. (Q36015579) (← links)
- 14-3-3 Proteins regulate mutant LRRK2 kinase activity and neurite shortening. (Q36402571) (← links)
- The Ever-Changing Morphology of Hippocampal Granule Neurons in Physiology and Pathology (Q36475393) (← links)
- Nestin-positive/SOX2-negative cells mediate adult neurogenesis of nigral dopaminergic neurons in mice (Q36586431) (← links)
- LRRK2: an éminence grise of Wnt-mediated neurogenesis? (Q36888947) (← links)
- Altered Development of Synapse Structure and Function in Striatum Caused by Parkinson's Disease-Linked LRRK2-G2019S Mutation (Q37080018) (← links)
- Development of inducible leucine-rich repeat kinase 2 (LRRK2) cell lines for therapeutics development in Parkinson's disease. (Q37249125) (← links)
- The function of orthologues of the human Parkinson's disease gene LRRK2 across species: implications for disease modelling in preclinical research (Q37513500) (← links)
- Parkinson's disease mouse models in translational research (Q37874160) (← links)
- Stem cell maintenance in the adult mammalian hippocampus: a matter of signal integration? (Q38001391) (← links)
- Ion channels in postnatal neurogenesis: potential targets for brain repair. (Q38012031) (← links)
- Adult neurogenesis in Parkinson's disease (Q38024276) (← links)
- Insights into LRRK2 function and dysfunction from transgenic and knockout rodent models (Q38044434) (← links)
- A link between LRRK2, autophagy and NAADP-mediated endolysosomal calcium signalling (Q38044445) (← links)
- The neurobiology of LRRK2 and its role in the pathogenesis of Parkinson's disease (Q38111307) (← links)
- Structural biology of the LRRK2 GTPase and kinase domains: implications for regulation (Q38213378) (← links)
- Genetics and genomics of Parkinson's disease (Q38233866) (← links)
- Neural stem cells in Parkinson's disease: a role for neurogenesis defects in onset and progression (Q38268886) (← links)